A5084535611- Bladder and Urothelial Cancer Treatments
- Chemotherapy-induced cardiotoxicity and mitigation
- Cardiac Imaging and Diagnostics
- Atrial Fibrillation Management and Outcomes
- Cancer Immunotherapy and Biomarkers
- Urinary and Genital Oncology Studies
- Multiple and Secondary Primary Cancers
- Cancer Diagnosis and Treatment
- Pain Management and Opioid Use
- Prostate Cancer Treatment and Research
- Advanced Breast Cancer Therapies
- Takotsubo Cardiomyopathy and Associated Phenomena
- Ethics and bioethics in healthcare
- Ethics in Clinical Research
- Viral-associated cancers and disorders
- Cancer, Lipids, and Metabolism
- Biomedical Ethics and Regulation
- Gastrointestinal Tumor Research and Treatment
- Esophageal Cancer Research and Treatment
- Healthcare Systems and Technology
- Patient-Provider Communication in Healthcare
- Urologic and reproductive health conditions
- Chemotherapy-related skin toxicity
- Pediatric Pain Management Techniques
- Cancer and Skin Lesions
Hospital Universitario Virgen Macarena
2011-2023
Sociedad Española de Oncología Médica
2017-2020
GEICAM – Spanish Breast Cancer Group
2020
Sociedad Española de Cardiología
2017
Hospital Privado
2005
Abstract Purpose Cancer patients require implantation of venous access devices to meet their personalized therapeutic needs, which are often complex due the nature medication and disease status. Therefore, it is essential have standardized protocols that guarantee best results in health patient safety. Methods To learn about availability aspects related safety clinical practice detect possible opportunities for improvement, a survey has been conducted various Spanish hospitals, addition...
The coming into force of Directive 2001/20/EC represented a step forward in harmonising clinical trial regulation European countries, guaranteeing uniform protection subjects participating research across Europe. However, it led to disproportionate increase the bureaucratization, and thus, became evident that procedures needed be simplified without detriment patient's safety. Thus, Regulation 536/2014, repealed 2001/20/EC, with aim decreasing growing bureaucratization stimulating Europe,...
Background: The aim of this study was to evaluate the impact certain single-nucleotide polymorphisms (SNPs) in cabazitaxel activity and toxicity patients with metastatic castration-resistant prostate cancer (mCRPC). Patients & methods: 56 SNPs five genes ( CYP3A4, CYP3A5, ABCB1, TUBB1 CYP2C8) were genotyped 67 mCRPC their correlation outcomes analyzed. Results: TUBB1-rs151352 (hazard ratio: 0.52) CYP2C8-rs1341164 0.53) associated better overall survival, CYP2C8-rs1058932 biochemical...